The global veterinary pharmaceutical drugs market size was valued at USD 57.24 billion in 2025 and is projected to grow from USD 61.54 billion in 2026 to USD 109.75 billion by 2034 at a CAGR of 7.5% during the forecast period 2026-2034. North America dominated the veterinary pharmaceutical drugs market with a market share of 39.2% in 2025.
Veterinary pharmaceutical drugs refer to medications explicitly formulated and approved for animal use to prevent, treat, or manage a range of medical disorders. These drugs target the distinct physiological and metabolic requirements of various animal species. They encompass anti-infectives, anti-inflammatory agents, parasiticides, vaccinations, and medicated feed additives. Veterinary pharmaceutical drugs have a wide reach, including all animal species, including domesticated and companion animals, and a diverse range of illnesses that can impact different species.
Download a Free Sample To learn more about this report,
Growing Adoption of Monoclonal Antibodies and Advanced Biologics for Animal Health
The veterinary pharmaceutical drugs market trends are increasingly driven by the growing use of biologics, monoclonal antibodies, and innovative therapies to treat chronic diseases in companion animals and livestock. Veterinary pharmaceutical companies are investing in targeted treatments for conditions such as osteoarthritis, atopic dermatitis, and pain management, offering longer-lasting efficacy and fewer side effects than conventional drugs. Rising pet ownership and increasing spending on animal healthcare are further accelerating demand for advanced veterinary medicines.
Rising Focus on Livestock Disease Prevention and Antimicrobial Stewardship
The veterinary pharmaceutical drugs market is witnessing strong growth as livestock producers increasingly adopt preventive healthcare strategies to improve animal productivity and reduce disease outbreaks. Growing emphasis on vaccination, parasite control, and responsible antimicrobial use is encouraging the development of innovative pharmaceuticals that enhance animal health while addressing concerns about antimicrobial resistance. Government initiatives and stricter regulations promoting sustainable livestock production are further supporting market expansion.
Rising Animal Healthcare Expenditure and Growing Livestock Population
The veterinary pharmaceutical drugs market growth is driven by increasing awareness of animal health, rising pet ownership, and the growing global livestock population. Farmers and pet owners are investing more in preventive healthcare, vaccinations, anti-infectives, parasiticides, and chronic disease management to improve animal welfare and productivity. The rising demand for high-quality meat, milk, eggs, and other animal-derived products has also encouraged livestock producers to adopt better veterinary care. The veterinary pharmaceutical drugs market growth is further supported by advancements in veterinary diagnostics, increasing availability of companion animal insurance, expanding veterinary clinics, and continuous innovation in biologics and specialty pharmaceuticals for both companion and farm animals.
Stringent Regulatory Requirements and High Drug Development Costs
The veterinary pharmaceutical drugs market faces significant restraints due to lengthy regulatory approval processes and the high cost of developing new veterinary medicines. Manufacturers must conduct extensive safety, efficacy, and residue studies before commercializing products, increasing research and development expenses. The veterinary pharmaceutical drugs market analysis also indicates that growing concerns regarding antimicrobial resistance have resulted in stricter regulations governing antibiotic use in food-producing animals. In addition, limited access to veterinary healthcare services in rural regions, fluctuating raw material prices, and pricing pressures in emerging markets continue to challenge industry growth.
Expansion of Biologics and Precision Animal Healthcare
The growing focus on preventive animal healthcare is creating significant opportunities for the veterinary pharmaceutical drugs market. Companies are investing in advanced vaccines, monoclonal antibodies, gene-based therapies, and long-acting injectable formulations to improve disease prevention and treatment outcomes. The veterinary pharmaceutical drugs market analysis highlights increasing adoption of precision livestock farming, wearable animal health monitoring devices, and digital veterinary platforms that enable early disease detection and personalized treatment. Rising demand for companion animal therapeutics and expanding veterinary healthcare infrastructure in developing economies are expected to create substantial long-term growth opportunities.
Controlling Antimicrobial Resistance and Ensuring Global Access
One of the major challenges facing the veterinary pharmaceutical drugs market is balancing effective disease management with responsible antimicrobial use. Increasing restrictions on antibiotic usage require manufacturers and veterinarians to develop alternative treatment strategies while maintaining animal health and productivity. The veterinary pharmaceutical drugs market growth is also affected by disease outbreaks, evolving regulatory standards, supply chain disruptions, and differences in veterinary healthcare infrastructure across regions. Ensuring affordable access to high-quality veterinary medicines while maintaining regulatory compliance and encouraging pharmaceutical innovation remains a key challenge for industry participants worldwide.
Request Customizationto receive a tailored report.
Production Animals Dominated the Market with 61.7% Share in 2025
The production animals segment accounted for the largest share of the global veterinary pharmaceutical drugs market at 61.7% in 2025, driven by the growing demand for livestock health management, disease prevention, productivity enhancement, and increasing consumption of meat, milk, and poultry products worldwide.
The companion animals segment is witnessing steady growth owing to rising pet ownership, increasing expenditure on animal healthcare, growing awareness of preventive treatments, and the availability of advanced veterinary medicines for chronic and infectious diseases.
Biologics are Projected to Register the Fastest Growth at a CAGR of 8.13%
The biologics segment is expected to expand at the highest CAGR of 8.13% during 2026–2034, supported by increasing adoption of veterinary vaccines, monoclonal antibodies, and immunotherapies for effective disease prevention and improved animal health.
Pharmaceuticals continue to represent a major product category due to their widespread use in treating bacterial, viral, parasitic, and chronic diseases across both livestock and companion animals. Medicated feed additives also remain an important segment, as they help improve animal nutrition, enhance feed efficiency, promote healthy growth, and reduce the incidence of diseases in commercial livestock production.
Speak to an Analystto discuss market opportunities.
North America accounted for a 38.5% veterinary pharmaceutical drugs market share, valued at USD 22.04 billion in 2025. The region's growth is driven by high pet ownership, increasing livestock healthcare expenditure, strong veterinary healthcare infrastructure, and the presence of leading animal health pharmaceutical companies. Rising awareness of animal disease prevention, growing adoption of preventive healthcare, and continuous innovation in veterinary medicines continue to support regional veterinary pharmaceutical drugs market growth.
The United States market accounted for the largest share of the North American market in 2025. Growth is driven by increasing pet adoption, rising spending on companion animal healthcare, expanding livestock disease management programmes, and strong investments in veterinary drug research and development. The presence of major animal health companies and advanced veterinary care further strengthens the country's market position.
Canada market is witnessing steady market growth due to increasing pet ownership, expanding veterinary healthcare services, growing awareness of animal welfare, and rising demand for vaccines, anti-infectives, and parasiticides for both companion and farm animals.
Europe market accounted for 27.4% of the global veterinary pharmaceutical drugs market, reaching USD 15.68 billion in 2025. Market growth is supported by stringent animal welfare regulations, increasing demand for livestock disease prevention, rising pet healthcare expenditure, and growing adoption of advanced veterinary pharmaceuticals. Continuous investments in animal health research and sustainable livestock management further drive regional demand.
The United Kingdom market is witnessing steady market growth owing to increasing companion animal ownership, expanding veterinary healthcare services, rising awareness of preventive animal healthcare, and growing demand for innovative veterinary medicines and vaccines.
Germany market represents one of the largest markets in Europe, driven by its well-established animal healthcare industry, increasing investments in veterinary pharmaceuticals, strong livestock production, and growing adoption of advanced animal disease management solutions.
Asia Pacific market accounted for 23.1% of the global veterinary pharmaceutical drugs market, valued at USD 13.22 billion in 2025, and is projected to register the fastest CAGR of 8.42% during the forecast period. The market is expanding due to rising livestock production, increasing pet ownership, growing awareness of animal health, and expanding veterinary healthcare infrastructure. Government initiatives supporting livestock disease control and increasing demand for animal-derived food products continue to support regional market growth.
Japan market is witnessing steady market growth due to increasing pet humanization, rising expenditure on companion animal healthcare, growing demand for preventive veterinary medicines, and continuous advancements in veterinary pharmaceutical research.
China market accounted for the largest share of the Asia Pacific market in 2025. Growth is supported by expanding livestock farming, increasing pet ownership, rising investments in veterinary healthcare infrastructure, and growing demand for vaccines, antibiotics, and animal nutrition products.
The Middle East & Africa market represented 4.8% of the global veterinary pharmaceutical drugs market, totaling USD 2.75 billion in 2025. Rising livestock production, increasing investments in animal healthcare services, growing awareness of disease prevention, and expanding veterinary infrastructure are supporting regional market growth.
The UAE market is a key market in the Middle East, driven by increasing investments in veterinary healthcare facilities, rising companion animal ownership, growing demand for livestock disease management, and expanding adoption of advanced veterinary pharmaceuticals.
Africa market is witnessing gradual market growth, supported by expanding livestock farming, increasing government initiatives for animal disease control, rising investments in veterinary healthcare services, and growing demand for vaccines and anti-infective drugs. Countries such as South Africa, Kenya, and Nigeria are creating long-term growth opportunities for market participants.
Unlock Regional Insightsto access country-level data, & regional trends.
Customize This Report to Match Your Strategic Objectives
Author's Details
Healthcare Lead
Debashree Bora is a Healthcare Lead with over 7 years of industry experience, specializing in Healthcare IT. She provides comprehensive market insights on digital health, electronic medical records, telehealth, and healthcare analytics. Debashree’s research supports organizations in adopting technology-driven healthcare solutions, improving patient care, and achieving operational efficiency in a rapidly transforming healthcare ecosystem.
We are featured on:
sales@straitsresearch.com